Gyre Therapeutics Inc

NASDAQ:GYRE 4:00:00 PM EDT

12.25

+0.44 (+3.73%)

4:30:28 PM EDT: $12.02 -0.23 (-1.88%)

Gyre Therapeutics Inc Stock, NASDAQ:GYRE

12770 High Bluff Drive, Suite 150, San Diego, California 92130

United States of America

Phone: +1.619.949.3681

Number of Employees: 4

http://www.gyretx.com

Description

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.